As of close of business last night, Cabaletta Bio Inc’s stock clocked out at $17.35, down -1.08% from its previous closing price of $17.54. In other words, the price has decreased by -$0.19 from its previous closing price. On the day, 1177217 shares were traded.
Ratios:
To gain a deeper understanding of CABA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.29 and its Current Ratio is at 15.29. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On November 29, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $38.
On October 24, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $40.Cantor Fitzgerald initiated its Overweight rating on October 24, 2023, with a $40 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 19 ’24 when Binder Gwendolyn sold 11,000 shares for $19.59 per share. The transaction valued at 215,439 led to the insider holds 20,000 shares of the business.
Binder Gwendolyn sold 11,000 shares of CABA for $240,789 on Dec 19 ’23. The insider now owns 20,000 shares after completing the transaction at $21.89 per share. On Nov 20 ’23, another insider, Binder Gwendolyn, who serves as the insider of the company, sold 11,000 shares for $17.82 each. As a result, the insider received 196,014 and left with 20,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 836.03M and an Enterprise Value of 599.80M.
Stock Price History:
Over the past 52 weeks, CABA has reached a high of $26.35, while it has fallen to a 52-week low of $6.94. The 50-Day Moving Average of the stock is 21.65, while the 200-Day Moving Average is calculated to be 16.88.
Shares Statistics:
It appears that CABA traded 895.03K shares on average per day over the past three months and 1.32M shares per day over the past ten days. A total of 47.82M shares are outstanding, with a floating share count of 33.75M. Insiders hold about 21.23% of the company’s shares, while institutions hold 96.27% stake in the company. Shares short for CABA as of Feb 29, 2024 were 7.01M with a Short Ratio of 7.83, compared to 6.39M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.36% and a Short% of Float of 18.54%.
Earnings Estimates
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.46 for the current quarter, with a high estimate of -$0.35 and a low estimate of -$0.57, while EPS last year was -$0.45. The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.25 and low estimates of -$0.57.
Analysts are recommending an EPS of between -$1.12 and -$2.29 for the fiscal current year, implying an average EPS of -$1.84. EPS for the following year is -$2.01, with 11 analysts recommending between -$0.94 and -$2.81.
